Fudan University is a national public research university in Shanghai, China. Fudan is a member of the C9 League, Project 985, Project 211, and the Double First Class University identified by the Ministry of Education of China.

During the past decade, Fudan University conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fudan University" #1 sponsor was "Fudan University" with 7 trials, followed by "3D Medicines (Sichuan) Co., Ltd." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "DualityBio Inc." with 1 trials sponsored and "International Breast Cancer Research Foundation" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fudan University" #1 collaborator was "Fudan University" with 2 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "CSPC Ouyi Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Caristo Diagnostics" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Fudan University" are "Hepatocellular Carcinoma" (2 trials), "Metastatic Pancreatic Cancer" (2 trials), "Airway Morbidity" (1 trials), "Breast Cancer" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Fudan University" in a lesser frequency.

Most popular intervention types in "Fudan University" are "Drug" (9 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biopsy" (1 trials), "DB-1303" (1 trials), "Donafenib" (1 trials), "Donafenib combined with TACE" (1 trials) and "Fresh air system with filtration" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fudan University" are 12 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Fudan University". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Fudan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fudan University, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Fudan University has several departments that took part in Clinical trials: "Department of Neurology, Huashan hospital, Fudan University" - 6 trials, "Department of Endocrinology, Zhongshan Hospital Fudan University" - 2 trials